Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Solid Tumor Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
F Hoffmann-La Roche Ltd
Bristol-Myers Squibb Company
AstraZeneca
Eli Lilly and Company
Celgene Corporation
Baxter
Amgen Limited & Amgen Ireland Limited
Johnson & Johnson
GlaxoSmithKline plc
Abbott Laboratories
By Type:
Small Molecules
Biologics
By Application:
Neurology
Oncology
Radiology
Others
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Solid Tumor Drug Market Overview 2018-2029
-
1.1 China Solid Tumor Drug Industry Development Overview
-
1.2 China Solid Tumor Drug Industry Development History
-
1.3 China Solid Tumor Drug Industry Market Size (2018-2029)
-
1.4 China Solid Tumor Drug Market Analysis by Type from Production Side
-
1.4.1 China Solid Tumor Drug Production Volume, Production Value and Growth Rate of Small Molecules (2018-2029)
-
1.4.2 China Solid Tumor Drug Production Volume, Production Value and Growth Rate of Biologics (2018-2029)
-
1.5 China Solid Tumor Drug Market Analysis by Application from Consumption End
-
1.5.1 China Solid Tumor Drug Sales Volume, Sales Value and Growth Rate of Neurology (2018-2029)
-
1.5.2 China Solid Tumor Drug Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)
-
1.5.3 China Solid Tumor Drug Sales Volume, Sales Value and Growth Rate of Radiology (2018-2029)
-
1.5.4 China Solid Tumor Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.6 China Solid Tumor Drug Market Analysis by Region
-
1.6.1 North China Solid Tumor Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Solid Tumor Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Solid Tumor Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Solid Tumor Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Solid Tumor Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Solid Tumor Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Solid Tumor Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Solid Tumor Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Solid Tumor Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Solid Tumor Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Solid Tumor Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Solid Tumor Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Solid Tumor Drug Industry Development
Chapter 3 Solid Tumor DrugIndustry Chain Analysis
-
3.1 Solid Tumor Drug Industry Chain
-
3.2 Solid Tumor Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Solid Tumor Drug Market
-
3.3 Solid Tumor Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Solid Tumor Drug Market
Chapter 4 China Solid Tumor Drug Market, by Type
-
4.1 China Solid Tumor Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Solid Tumor Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Solid Tumor Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Solid Tumor Drug Production Volume and Growth Rate of Small Molecules
-
4.5.2 China Solid Tumor Drug Production Volume and Growth Rate of Biologics
Chapter 5 China Solid Tumor Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Solid Tumor Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Solid Tumor Drug Market Size and Growth Rate, by Application
-
5.5.1 China Solid Tumor Drug Market Size and Growth Rate of Neurology
-
5.5.2 China Solid Tumor Drug Market Size and Growth Rate of Oncology
-
5.5.3 China Solid Tumor Drug Market Size and Growth Rate of Radiology
-
5.5.4 China Solid Tumor Drug Market Size and Growth Rate of Others
Chapter 6 China Solid Tumor Drug Market, by Region
-
6.1 China Solid Tumor Drug Production Volume and Production Value, by Region
-
6.2 China Solid Tumor Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Solid Tumor Drug Market Analysis
-
7.1 North China Solid Tumor Drug Market, by Type
-
7.2 North China Solid Tumor Drug Market, by Application
Chapter 8 Central China Solid Tumor Drug Market Analysis
-
8.1 Central China Solid Tumor Drug Market, by Type
-
8.2 Central China Solid Tumor Drug Market, by Application
Chapter 9 South China Solid Tumor Drug Market Analysis
-
9.1 South China Solid Tumor Drug Market, by Type
-
9.2 South China Solid Tumor Drug Market, by Application
Chapter 10 East China Solid Tumor Drug Market Analysis
-
10.1 East China Solid Tumor Drug Market, by Type
-
10.2 East China Solid Tumor Drug Market, by Application
Chapter 11 Northeast China Solid Tumor Drug Market Analysis
-
11.1 Northeast China Solid Tumor Drug Market, by Type
-
11.2 Northeast China Solid Tumor Drug Market, by Application
Chapter 12 Southwest China Solid Tumor Drug Market Analysis
-
12.1 Southwest China Solid Tumor Drug Market, by Type
-
12.2 Southwest China Solid Tumor Drug Market, by Application
Chapter 13 Northwest China Solid Tumor Drug Market Analysis
-
13.1 Northwest China Solid Tumor Drug Market, by Type
-
13.2 Northwest China Solid Tumor Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 F Hoffmann-La Roche Ltd
-
14.1.1 F Hoffmann-La Roche Ltd Company Profile
-
14.1.2 F Hoffmann-La Roche Ltd Solid Tumor Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Bristol-Myers Squibb Company
-
14.2.1 Bristol-Myers Squibb Company Company Profile
-
14.2.2 Bristol-Myers Squibb Company Solid Tumor Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 AstraZeneca
-
14.3.1 AstraZeneca Company Profile
-
14.3.2 AstraZeneca Solid Tumor Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Eli Lilly and Company
-
14.4.1 Eli Lilly and Company Company Profile
-
14.4.2 Eli Lilly and Company Solid Tumor Drug Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Celgene Corporation
-
14.5.1 Celgene Corporation Company Profile
-
14.5.2 Celgene Corporation Solid Tumor Drug Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Baxter
-
14.6.1 Baxter Company Profile
-
14.6.2 Baxter Solid Tumor Drug Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Amgen Limited & Amgen Ireland Limited
-
14.7.1 Amgen Limited & Amgen Ireland Limited Company Profile
-
14.7.2 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Johnson & Johnson
-
14.8.1 Johnson & Johnson Company Profile
-
14.8.2 Johnson & Johnson Solid Tumor Drug Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 GlaxoSmithKline plc
-
14.9.1 GlaxoSmithKline plc Company Profile
-
14.9.2 GlaxoSmithKline plc Solid Tumor Drug Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Abbott Laboratories
-
14.10.1 Abbott Laboratories Company Profile
-
14.10.2 Abbott Laboratories Solid Tumor Drug Market Performance
-
14.10.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Solid Tumor Drug Industry Research Conclusions
-
15.2 Solid Tumor Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Solid Tumor Drug Industry Market Size (2018-2029)
-
Figure China Solid Tumor Drug Production Volume, Production Value and Growth Rate of Small Molecules (2018-2029)
-
Figure China Solid Tumor Drug Production Volume, Production Value and Growth Rate of Biologics (2018-2029)
-
Figure China Solid Tumor Drug Sales Volume, Sales Value and Growth Rate of Neurology (2018-2029)
-
Figure China Solid Tumor Drug Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)
-
Figure China Solid Tumor Drug Sales Volume, Sales Value and Growth Rate of Radiology (2018-2029)
-
Figure China Solid Tumor Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure North China Solid Tumor Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Solid Tumor Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Solid Tumor Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Solid Tumor Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Solid Tumor Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Solid Tumor Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Solid Tumor Drug Market Size and Growth Rate from 2018-2029
-
Figure Solid Tumor Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Solid Tumor Drug Market Share by Type in 2018
-
Figure China Solid Tumor Drug Market Share by Type in 2023
-
Figure China Solid Tumor Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Solid Tumor Drug Production Volume and Growth Rate of Small Molecules (2018-2023)
-
Figure China Solid Tumor Drug Production Volume and Growth Rate of Biologics (2018-2023)
-
Figure China Solid Tumor Drug Market Share by Application in 2018
-
Figure China Solid Tumor Drug Market Share by Application in 2023
-
Figure China Solid Tumor Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Solid Tumor Drug Market Size and Growth Rate of Neurology (2018-2023)
-
Figure China Solid Tumor Drug Market Size and Growth Rate of Oncology (2018-2023)
-
Figure China Solid Tumor Drug Market Size and Growth Rate of Radiology (2018-2023)
-
Figure China Solid Tumor Drug Market Size and Growth Rate of Others (2018-2023)
-
Table China Solid Tumor Drug Production Volume by Region (2018-2023)
-
Table China Solid Tumor Drug Production Volume Share by Region (2018-2023)
-
Figure China Solid Tumor Drug Production Volume Share by Region (2018-2023)
-
Table China Solid Tumor Drug Production Value by Region (2018-2023)
-
Table China Solid Tumor Drug Production Value Share by Region (2018-2023)
-
Figure China Solid Tumor Drug Production Value Share by Region (2018-2023)
-
Table China Solid Tumor Drug Sales Volume by Region (2018-2023)
-
Table China Solid Tumor Drug Sales Volume Share by Region (2018-2023)
-
Figure China Solid Tumor Drug Sales Volume Share by Region (2018-2023)
-
Table China Solid Tumor Drug Sales Value by Region (2018-2023)
-
Table China Solid Tumor Drug Sales Value Share by Region (2018-2023)
-
Figure China Solid Tumor Drug Sales Value Share by Region (2018-2023)
-
Table North China Solid Tumor Drug Production Volume by Type (2018-2023)
-
Table North China Solid Tumor Drug Production Volume Share by Type (2018-2023)
-
Figure North China Solid Tumor Drug Production Volume Share by Type (2018-2023)
-
Table North China Solid Tumor Drug Sales Volume by Application (2018-2023)
-
Table North China Solid Tumor Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Solid Tumor Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Solid Tumor Drug Production Volume by Type (2018-2023)
-
Table Central China Solid Tumor Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Solid Tumor Drug Production Volume Share by Type (2018-2023)
-
Table Central China Solid Tumor Drug Sales Volume by Application (2018-2023)
-
Table Central China Solid Tumor Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Solid Tumor Drug Sales Volume Share by Application (2018-2023)
-
Table South China Solid Tumor Drug Production Volume by Type (2018-2023)
-
Table South China Solid Tumor Drug Production Volume Share by Type (2018-2023)
-
Figure South China Solid Tumor Drug Production Volume Share by Type (2018-2023)
-
Table South China Solid Tumor Drug Sales Volume by Application (2018-2023)
-
Table South China Solid Tumor Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Solid Tumor Drug Sales Volume Share by Application (2018-2023)
-
Table East China Solid Tumor Drug Production Volume by Type (2018-2023)
-
Table East China Solid Tumor Drug Production Volume Share by Type (2018-2023)
-
Figure East China Solid Tumor Drug Production Volume Share by Type (2018-2023)
-
Table East China Solid Tumor Drug Sales Volume by Application (2018-2023)
-
Table East China Solid Tumor Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Solid Tumor Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Solid Tumor Drug Production Volume by Type (2018-2023)
-
Table Northeast China Solid Tumor Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Solid Tumor Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Solid Tumor Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Solid Tumor Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Solid Tumor Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Solid Tumor Drug Production Volume by Type (2018-2023)
-
Table Southwest China Solid Tumor Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Solid Tumor Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Solid Tumor Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Solid Tumor Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Solid Tumor Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Solid Tumor Drug Production Volume by Type (2018-2023)
-
Table Northwest China Solid Tumor Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Solid Tumor Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Solid Tumor Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Solid Tumor Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Solid Tumor Drug Sales Volume Share by Application (2018-2023)
-
Table F Hoffmann-La Roche Ltd Company Profile
-
Table F Hoffmann-La Roche Ltd Solid Tumor Drug Revenue, Price and Gross (2018-2023)
-
Table Bristol-Myers Squibb Company Company Profile
-
Table Bristol-Myers Squibb Company Solid Tumor Drug Revenue, Price and Gross (2018-2023)
-
Table AstraZeneca Company Profile
-
Table AstraZeneca Solid Tumor Drug Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly and Company Company Profile
-
Table Eli Lilly and Company Solid Tumor Drug Revenue, Price and Gross (2018-2023)
-
Table Celgene Corporation Company Profile
-
Table Celgene Corporation Solid Tumor Drug Revenue, Price and Gross (2018-2023)
-
Table Baxter Company Profile
-
Table Baxter Solid Tumor Drug Revenue, Price and Gross (2018-2023)
-
Table Amgen Limited & Amgen Ireland Limited Company Profile
-
Table Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Revenue, Price and Gross (2018-2023)
-
Table Johnson & Johnson Company Profile
-
Table Johnson & Johnson Solid Tumor Drug Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline plc Company Profile
-
Table GlaxoSmithKline plc Solid Tumor Drug Revenue, Price and Gross (2018-2023)
-
Table Abbott Laboratories Company Profile
-
Table Abbott Laboratories Solid Tumor Drug Revenue, Price and Gross (2018-2023)
-
